A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between normal and pancreatic cancer cells in mice, and that the normal cells may ...

Real Housewives of Beverly Hills’ alum Teddi Mellencamp, 43, confirmed that her cancer has reached stage 4 after her melanoma ...

The job of T cells is to help the body kill cancer cells and control the immune ... harmless and temporary situation due to the body’s normal response to an infection or inflammatory condition.

A new kind of vaccine is changing how people think about preventing breast cancer. Not just any breast cancer—this one ...

Diseased brain cells adapt to preserve functions under normal conditions, but modest stressors accelerate decline. Understanding this adaptation to stress could lead to new targets for cancer ...

You need these cells to carry oxygen around your ... very often for PV because it also can make blood cancer (leukemia) more likely. It’s normal to have a mix of emotions when you have a serious ...

Researchers from the Department of Pathology, School of Clinical Medicine at the LKS Faculty of Medicine of the University of ...

One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules ...

Researchers from the University of Colorado Cancer Center have solved a cellular ... eventually recover the intestine and turn back to normal cells." Scientists have been looking for a long ...